Russel Burge, PhD

Eli Lilly and Company
Indianapolis, United States

Presentation(s):

• 0362: Drug Persistence of IL-17A Inhibitors Among Patients with PsA: Real-World Data from the CorEvitas PsA/SpA Registry

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure information not submitted.